Skip to main content
Vil du afgive tilbud på offentlige udbud? Se vores TaaS-service til forberedelse af udbud
Udbud

NHS Mærkevarer Medicin Tranche A - NOFE og Midlands & East og Natalizumab for London & SOFE - 1. september 2026

Åben
Frist
13 dage tilbage
April 17, 2026
Kontrakt detaljer
Kategori
Open Procedure
Reference
023990-2026
Værdi
£1,053,204,684
Lokation
North East England, Storbritannien
Udgivet
Marts 28, 2026
Organisation
CPV-kode
Projekttidslinje

Udbud offentliggjort

Marts 17, 2026

Frist for spørgsmål

April 10, 2026

Frist for tilbud

April 17, 2026

Kontraktens startdato

August 31, 2026

OrdregiverindsigtPRO
🔒
Lås op for ordregiverindsigt
Se forbrugsmønstre, foretrukne procedurer og mere.
Opgrader til Professionel →
Budget
£1,053,204,684
Varighed
24 måneder
Lokation
North East England
Type
Open Procedure
75
Kvalitetsscore/100
God

Original udbudsbeskrivelse

NHS Mærkevare Rammeaftale – Lot 1 – Tranche A for Nordengland og Midlands & East. Rammeaftalens periode: 1. september 2026 til 31. august 2028 med en eller flere muligheder for forlængelse (efter myndighedens skøn i yderligere 24 måneder. Lot 2 – Natalizumab for London og Sydengland. Rammeaftalens periode: 1. september 2026 til 31. august 2027 med en eller flere muligheder for forlængelse i yderligere 12 måneder.

Risikoanalyse

Risikoanalyse er endnu ikke tilgængelig for dette lands udbud. Understøttede lande i øjeblikket: Estland, Polen, Litauen og Letland.

Vinderstrategi

Få en AI-drevet vinderstrategi skræddersyet til dette udbud. Inkluderer sandsynlighedsscore for at vinde, vigtige muligheder og udfordringer, anbefalede fokusområder for tilbuddet, indsigt i konkurrencepositionering og handlingsrettede anbefalinger for at maksimere dine chancer.

Log ind

Konkurrenter

Opgrader for at se, hvilke virksomheder der sandsynligvis vil afgive tilbud på dette udbud, baseret på historiske indkøbsdata.

Log ind

Krav og kvalifikationer

7 krav på tværs af 5 kategorier

Indsendelse (2)
Obligatorisk (1)
Overholdelse (2)
Teknisk (1)
Finansiel (1)
SUBMISSION REQUIREMENTS2
--Bids must be submitted by the deadline: 2026-04-17T13:00:00+01:00.
--Requirements are to be provided in English, Estonian, Latvian, Polish, and Lithuanian.
MANDATORY EXCLUSION GROUNDS1
--No specific mandatory exclusion grounds are detailed in the provided text.
ELIGIBILITY REQUIREMENTS2
--Bidders must be capable of supplying pharmaceutical products (CPV: 33600000).
--Bidders must be able to meet the requirements for Lot 1 (North of England and Midlands & East) or Lot 2 (London and South of England) or both.
TECHNICAL CAPABILITY REQUIREMENTS1
--No specific technical capability requirements are detailed in the provided text.
FINANCIAL REQUIREMENTS1
--No specific financial requirements are detailed in the provided text.

Forhåndsvisning af Krav

Tilmeld dig for at se komplette krav og analyser

Dokumenter

Få AI-genererede resuméer af alle udbudsdokumenter. Forstå hurtigt, hvad hvert dokument indeholder, uden at læse hundredvis af sider — dækkende omfang, betingelser, evalueringskriterier og vigtige forpligtelser.

Log ind
75
God

Udbudskvalitetsscore

This tender is generally well-structured with a clear title, reference, and estimated value. However, it lacks specific details on evaluation criteria and technical/financial requirements, and the submission deadline may be tight.

Scoreopdeling

Overholdelse af lovgivning75/100

The tender adheres to standard open procedure and provides a CPV code. Deadlines are present, though the submission deadline could be considered short. No disputes are indicated. Regulatory compliance is assumed based on the provided information.

Klarhed80/100

The description of the framework agreement and its lots is clear. Eligibility requirements are stated. However, the absence of specific technical and financial requirements, as well as evaluation criteria, reduces overall clarity.

Missing evaluation criteria specified
Fuldstændighed70/100

Basic information such as title, reference, organization, value, and deadlines are present. The duration of the framework agreement is specified. However, crucial details regarding technical capabilities, financial standing, and evaluation criteria are missing, impacting completeness.

No specific technical capability requirements detailed
No specific financial requirements detailed
Retfærdighed85/100

The tender is an open procedure, allowing broad access. The estimated value is disclosed. The division into lots promotes competition. No specific company tailoring is evident. The primary concern is the lack of detailed criteria, which could lead to subjective evaluation if not addressed.

Praktisk anvendelighed65/100

The contract start date is specified. Financing information is not detailed. The tender mentions requirements in multiple languages, which is a positive aspect for broader participation. However, the lack of explicit e-submission details and the absence of document content in the provided text hinder practicality.

No e-submission specified
No document content available
Datakonsistens90/100

Key fields like title, reference, organization, value, and deadlines are populated. Dates are logical and do not indicate suspension or disputes. The CPV code and NUTS code are provided.

Bæredygtighed50/100

There is no explicit mention of green procurement, social aspects, or innovation within the provided tender information. The tender is not indicated as EU funded.

Not green procurement
No social criteria

Styrker

Clear title and reference number
Estimated value disclosed
Open procedure for broad participation
Division into lots
Requirements in multiple languages

Bekymringer

Missing specific technical and financial requirements
No evaluation criteria specified
Submission deadline may be too short
No document content available

Anbefalinger

1. Provide detailed technical and financial capability requirements.
2. Clearly define evaluation criteria.
3. Ensure sufficient time for bid preparation and submission.

Forhåndsvisning af AI-scoring

Tilmeld dig for at se komplette krav og analyser

Komplet analyse af kvalitetsscore
Detaljeret opdeling af underscores
Indsigter i styrker og bekymringer
Strategiske anbefalinger

Intet kreditkort krævet • Opsætning på 2 minutter

Ny service

Vil du have os til at håndtere dette udbud?

Vores udbudseksperter forbereder alt. Det virker – du gennemgår, godkender og indsender.

~1hDin tid kun
80%+80%+
$0Forudbetaling
Se fuld sammenligning
Uden TaaSMed TaaS
40-80 timer
Forberedelsestid
~1 time
Din tid kun
15-25%
Gennemsnitlig vinderate
80%+
Vinderate
Risiko for fejl
Manuel gennemgang
Ekspert QA
Overholdelsestjek
Du gør alt
Håndter alt
Vi gør alt
End-to-end service
Lad os vinde dette udbud
Betal kun, når du vinder · 400+ virksomheder stoler på os
Eller gør det selv

Tilføj til pipeline